• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振成像对心脏性猝死一级预防和二级预防的作用:当代的实用性与局限性

Cardiac magnetic resonance imaging contributing to primary prevention and secondary prevention of sudden cardiac death: Contemporary usefulness and limitations.

作者信息

Amano Yasuo, Iso Kazuki, Suzuki Yasuyuki, Tachi Masaki

机构信息

Department of Radiology, Nihon University Hospital, Tokyo 1018309, Japan.

Department of Cardiology, Nihon University Hospital, Tokyo 1018309, Japan.

出版信息

World J Radiol. 2025 Jul 28;17(7):107140. doi: 10.4329/wjr.v17.i7.107140.

DOI:10.4329/wjr.v17.i7.107140
PMID:40746520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308606/
Abstract

Sudden cardiac death (SCD) is one of the most devastating sequelae of myocardial diseases and can be the initial symptom in younger athletes or middle-aged businesspeople. An implantable cardioverter defibrillator (ICD) prevents SCD and dramatically reduces the arrhythmic events in these patients; hence, the risk stratification for the SCD is important. In survivors of out-of-hospital cardiac arrest, identification of its etiologies is required to select the appropriate treatments following ICD installation. Cardiac magnetic resonance imaging (MRI) is useful for evaluating the morphology and function of the heart and for tissue characterization, MRI can therefore be used to stratify the risk of SCD associated with various myocardial diseases and leads to primary prevention using ICD. MRI can predict arrhythmic events, which suggest the progression of myocardial damage, following secondary prevention. In this review, we provide a clinical and MRI focused update and MRI protocol for the primary and secondary prevention of SCD. We summarize the contribution and limitations of cardiac MRI for prevention SCD using ICD implantation.

摘要

心脏性猝死(SCD)是心肌疾病最具破坏性的后遗症之一,可能是年轻运动员或中年商务人士的首发症状。植入式心脏复律除颤器(ICD)可预防SCD,并显著减少这些患者的心律失常事件;因此,SCD的风险分层很重要。在院外心脏骤停幸存者中,需要确定其病因,以便在安装ICD后选择合适的治疗方法。心脏磁共振成像(MRI)有助于评估心脏的形态和功能以及进行组织特征分析,因此MRI可用于对与各种心肌疾病相关的SCD风险进行分层,并指导使用ICD进行一级预防。MRI可预测二级预防后提示心肌损伤进展的心律失常事件。在本综述中,我们提供了以临床和MRI为重点的SCD一级和二级预防的最新进展及MRI方案。我们总结了心脏MRI在使用ICD植入预防SCD方面的作用和局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/0835f897a4e5/wjr-17-7-107140-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/4d92ee81fba2/wjr-17-7-107140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/046e7219eea6/wjr-17-7-107140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/f908adc604cc/wjr-17-7-107140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/30f2a824cd8a/wjr-17-7-107140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/6443a97e50bd/wjr-17-7-107140-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/100fd9e70994/wjr-17-7-107140-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/c19cbce8b962/wjr-17-7-107140-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/9ac73a6b7f04/wjr-17-7-107140-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/c1185ee1193b/wjr-17-7-107140-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/69e0d2ddab1f/wjr-17-7-107140-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/0835f897a4e5/wjr-17-7-107140-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/4d92ee81fba2/wjr-17-7-107140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/046e7219eea6/wjr-17-7-107140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/f908adc604cc/wjr-17-7-107140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/30f2a824cd8a/wjr-17-7-107140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/6443a97e50bd/wjr-17-7-107140-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/100fd9e70994/wjr-17-7-107140-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/c19cbce8b962/wjr-17-7-107140-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/9ac73a6b7f04/wjr-17-7-107140-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/c1185ee1193b/wjr-17-7-107140-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/69e0d2ddab1f/wjr-17-7-107140-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/12308606/0835f897a4e5/wjr-17-7-107140-g011.jpg

相似文献

1
Cardiac magnetic resonance imaging contributing to primary prevention and secondary prevention of sudden cardiac death: Contemporary usefulness and limitations.心脏磁共振成像对心脏性猝死一级预防和二级预防的作用:当代的实用性与局限性
World J Radiol. 2025 Jul 28;17(7):107140. doi: 10.4329/wjr.v17.i7.107140.
2
Implantable defibrillators versus medical therapy for cardiac channelopathies.植入式除颤器与心脏离子通道病的药物治疗对比
Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD011168. doi: 10.1002/14651858.CD011168.pub2.
3
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
4
Late Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者的延迟钆增强
Pacing Clin Electrophysiol. 2016 Jul;39(7):731-47. doi: 10.1111/pace.12873. Epub 2016 May 19.
5
Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure.优化心力衰竭患者心源性猝死的一级预防
J Am Coll Cardiol. 2025 Aug 5;86(5):374-395. doi: 10.1016/j.jacc.2025.05.061.
6
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.胺碘酮与其他预防心源性猝死的药物干预措施的比较
Cochrane Database Syst Rev. 2015 Dec 8;2015(12):CD008093. doi: 10.1002/14651858.CD008093.pub2.
7
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.晚期钆增强与扩张型心肌病中心律失常或猝死风险:系统评价和荟萃分析。
JACC Heart Fail. 2017 Jan;5(1):28-38. doi: 10.1016/j.jchf.2016.09.017. Epub 2016 Dec 21.
8
Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review.有和没有植入式心脏复律除颤器的可逆转病因的心脏骤停幸存者中复发性室性心律失常和死亡率:系统评价。
Resuscitation. 2022 Apr;173:76-90. doi: 10.1016/j.resuscitation.2022.02.019. Epub 2022 Feb 25.
9
Sudden Cardiac Death心脏性猝死
10
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.

本文引用的文献

1
Early Identification of Myocardial Microstructural Alterations in Hypertrophic Cardiomyopathy with in Vivo Cardiac Diffusion-Tensor Imaging.利用活体心脏扩散张量成像技术早期识别肥厚型心肌病的心肌微观结构改变
Radiol Cardiothorac Imaging. 2025 Feb;7(1):e240009. doi: 10.1148/ryct.240009.
2
Diagnosis and management of hypertrophic cardiomyopathy: European vs. American guidelines.肥厚型心肌病的诊断与管理:欧洲与美国指南对比
Heart Fail Rev. 2025 Mar;30(2):315-325. doi: 10.1007/s10741-024-10464-0. Epub 2024 Nov 9.
3
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR 肥厚型心肌病管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2024 Jun 4;149(23):e1239-e1311. doi: 10.1161/CIR.0000000000001250. Epub 2024 May 8.
4
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.《心脏结节病的诊断与治疗:美国心脏协会科学声明》。
Circulation. 2024 May 21;149(21):e1197-e1216. doi: 10.1161/CIR.0000000000001240. Epub 2024 Apr 18.
5
Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis.晚期钆增强与扩张型心肌病预后的关联:一项荟萃分析。
World J Radiol. 2023 Nov 28;15(11):324-337. doi: 10.4329/wjr.v15.i11.324.
6
Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.缺血性心肌病与非缺血性扩张型心肌病的间隔壁中层钆延迟增强-特点和预后。
Am J Cardiol. 2023 Aug 15;201:294-301. doi: 10.1016/j.amjcard.2023.06.042. Epub 2023 Jun 30.
7
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
8
Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy.细胞外容积分数可改善非缺血性心肌病患者室性心律失常和猝死的风险分层。
Eur Heart J Cardiovasc Imaging. 2023 Mar 21;24(4):512-521. doi: 10.1093/ehjci/jeac142.
9
Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.病毒性心肌炎:分类、诊断及临床意义
Front Cardiovasc Med. 2022 Jun 20;9:908663. doi: 10.3389/fcvm.2022.908663. eCollection 2022.
10
Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD-What We Still Don't Know.植入式心脏复律除颤器在心脏性猝死一级和二级预防中的应用——我们仍未知晓的情况
J Cardiovasc Dev Dis. 2022 Apr 16;9(4):120. doi: 10.3390/jcdd9040120.